1- Genome-wide genetic analyses highlight mitogen-activated protein kinase (MAPK) signaling in the pathogenesis of endometriosis. Hum Reprod 2017 Feb 9:1-14. doi: 10.1093/humrep/dex024.
2- Soluble VCAM-1/soluble ICAM-1 ratio is a promising biomarker for diagnosing endometriosis. Hum Reprod 2017 Feb 23:1-10. doi: 10.1093/humrep/dex028.
3- Endometriosis education in schools: A New Zealand model examining the impact of an education program in schools on early recognition of symptoms suggesting endometriosis. Aust N Z J Obstet Gynaecol. 2017 Mar 28. doi: 10.1111/ajo.12614.
4- Non-ART pregnancy predictive factors in infertile patients with peritoneal superficial endometriosis. Eur J Obstet Gynecol Reprod Biol 2017 Mar 7;211:182-187. doi: 10.1016/j.ejogrb.2017.03.008.
5- Endometriosis is associated with aberrant metabolite profiles in plasma. Fertil Steril 2017 Mar;107(3):699-706.e6. doi: 10.1016/j.fertnstert.2016.12.032.
6- Introduction: A focus on the medical management of endometriosis. Fertil Steril 2017 Mar;107(3):521-522. doi: 10.1016/j.fertnstert.2017.01.008.
7- Mu opioid receptor in the human endometrium: dynamics of its expression and localization during the menstrual cycle. Fertil Steril 2017 Feb 27. pii: S0015-0282(17)30079-1. doi: 10.1016/j.fertnstert.2017.01.020.
8- Clinicians' perceptions of women's experiences of endometriosis and of psychosocial care for endometriosis. Aust N Z J Obstet Gynaecol 2017 Feb;57(1):87-92. doi: 10.1111/ajo.12571.
9- Genetic risk factors for ovarian cancer and their role for endometriosis risk. Gynecol Oncol 2017 Apr;145(1):142-147. doi: 10.1016/j.ygyno.2017.02.022.
10- Biomarkers in endometriosis: challenges and opportunities. Fertil Steril 2017 Mar;107(3):523-532. doi: 10.1016/j.fertnstert.2017.01.009.
11- Surgery for endometriosis: beyond medical therapies. Fertil Steril 2017 Mar;107(3):549-554. doi: 10.1016/j.fertnstert.2017.01.001.
12- Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents. J Pediatr Adolesc Gynecol 2017 Feb 9. pii: S1083-3188(17)30036-0. doi: 10.1016/j.jpag.2017.01.014.
13- Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertil Steril 2017 Mar;107(3):533-536. doi: 10.1016/j.fertnstert.2017.01.003.
14- Long-term medical management of endometriosis with dienogest and with a gonadotropin-releasing hormone agonist and add-back hormone therapy. Fertil Steril 2017 Mar;107(3):537-548. doi: 10.1016/j.fertnstert.2016.12.024.
15- Does preoperative antimüllerian hormone level influence postoperative pregnancy rate in women undergoing surgery for severe endometriosis? Fertil Steril 2017 Mar;107(3):707-713.e3. doi: 10.1016/j.fertnstert.2016.12.013.
16- Prognostic factors for assisted reproductive technology in women with endometriosis-related infertility. Am J Obstet Gynecol 2017 Mar;216(3):280.e1-280.e9. doi: 10.1016/j.ajog.2016.11.1042.
17- Effects of long-term postoperative dienogest use for treatment of endometriosis on bone mineral density. Eur J Obstet Gynecol Reprod Biol 2017 Mar 6;212:9-12. doi: 10.1016/j.ejogrb.2017.03.011.
18- Dienogest and deep infiltrating endometriosis: The remission of symptoms is not related to endometriosis nodule remission. Eur J Obstet Gynecol Reprod Biol 2017 Apr;211:108-111. doi: 10.1016/j.ejogrb.2017.02.015.
19- Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses. Cancer Causes Control 2017 Mar 15. doi: 10.1007/s10552-017-0856-4.
